Testing effectiveness (Phase 2)UnknownNCT05302024
What this trial is testing
Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 100